AzTrials
AzTrials

HIV InfectionNCT01953653

Feasibility of Using a Structured Daily Diary

A study testing Structured daily diary in people with HIV Infection, run by University of North Carolina, Chapel Hill at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This protocol explores the feasibility and acceptability of using two daily diary methods to analyze state-dependent variables and psychosocial health outcomes in Human Immunodeficiency Virus (HIV)-positive young men who have sex with men (YMSM). Read more about this study

Who is it for?
Ages 16 to 24 years, men only
Conditions the study is for
HIV Infection
What is being tested?
Structured daily diary
Could I receive a placebo?
No, everyone receives an active treatment
How many people
67 participants
Where
3 sitesUnited States
Study dates
Feb 2013to Feb 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 24 years
  • Men only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Receives services at one of the selected Adolescent Medicine Trial Unit (AMTU) sites;
  • HIV-1 infection as documented in the participant's medical record by at least one of the following criteria:
  • Reactive HIV screening test result with an antibody-based, Food and Drug Administration (FDA)-licensed assay followed by a positive supplemental assay (e.g., HIV-1 Western Blot, HIV-1 indirect immunofluorescence);
  • Positive HIV-1 deoxyribonucleic acid (DNA) polymerase chain reaction (PCR) assay;
  • Plasma HIV-1 quantitative ribonucleic acid (RNA) assay >1,000 copies/mL; or
  • Positive plasma HIV-1 RNA qualitative assay
Show all 16Show fewer
  • Between the ages of 16-24 years, inclusive, at the time of screening;
  • Born biologically male and self-identifies as male at the time of screening;
  • HIV-infected through sexual behavior;
  • At least one self-reported sexual encounter with another man involving oral or anal sex in the past 12 months prior to screening;
  • At least one self-reported episode of unprotected vaginal or anal intercourse within the past 90 days prior to screening and/or substance use, defined as at least one occasion in which four or more alcoholic beverages were consumed and/or two or more occasions of illicit drug use, in the past 90 days, as assessed by the Assessment of Substance Use and Sexual Behavior questionnaire (CRF (F107));
  • Has active cell phone service; is able to access his cell phone seven days a week between 6:00 PM and 6:00 AM the next morning; and is willing and able to use approximately 10 minutes of talk time and receive two text messages per day;
  • Consistent internet access seven days a week between 6:00 PM and 6:00 AM the next morning;
  • Ability to understand, read, and speak English;
  • Ability to read at a fifth grade level, as assessed by the Rapid Estimate of Adolescent Literacy in Medicine (REALM)-TEEN; and
  • Willingness to provide signed informed consent for study participation.

Who cannot join

  • HIV infected via modes other than sexual behavior (e.g., perinatally, via shared needles, or blood transfusion, etc.);
  • Previously enrolled in Adolescent Trials Network (ATN) 112;
  • Active psychiatric condition that in the opinion of the site Principal Investigator (PI) or designee would interfere with the ability to give true informed consent and to adhere to the study requirements;
  • Visibly distraught and/or visibly emotionally unstable (e.g., exhibiting suicidal, homicidal, impulsive or violent behavior);
  • Active drug or alcohol use or dependence that, in the opinion of the site personnel, would interfere with the ability to give true informed consent and to adhere to the study requirements;
  • Acute illness that, in the opinion of the treating clinician, would interfere with the participant's ability to adhere to the protocol requirements and/or interfere with the protocol objectives.

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Children's Hospital of Denver

    Aurora, Colorado, 80045

  • Wayne State University

    Detroit, Michigan, 48201

  • Childrens Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Official title: Feasibility of Using a Structured Daily Diary to Assess Mood, Stressful Events, Support, Substance Use, and Sexual Behavior in HIV-Positive Young Men Who Have Sex With Men

This protocol explores the feasibility and acceptability of using two daily diary methods to analyze state-dependent variables and psychosocial health outcomes in Human Immunodeficiency Virus (HIV)-positive young men who have sex with men (YMSM). The study will explore the potential of diaries for use in feedback-based interventions.

Conditions
HIV Infection
Being tested
Structured daily diary
Medical subject headings
HIV Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Structured daily diaryBehavioural

    The intervention is a structured daily diary to describe fluctuations in key psychological and behavioral variables impacting daily risk behavior among HIV-positive young men who have sex with men (YMSM), aged 16 to 24 years old who engage in substance use and sexual risk behaviors.

Study groups in NCT01953653
Study groupRoleWhat they receive
A: Begin with Interactive Voice Response (IVR) SystemOtherGroup A participants are randomized the IVR system as Modality #1. After 33 days of diary completion using IVR, they switch to the interactive web response system (IWR)as Modality #2.
Receives: Behavioral: Structured daily diary
B: Begin with Interactive Web Response (IWR) SystemOtherGroup B participants are randomized to the IWR system as Modality #1. After 33 days of diary completion using IWR, they switch to the interactive voice response (IVR)system as Modality #2.
Receives: Behavioral: Structured daily diary

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants who Complete the 66-Day Structured Daily Diary

    The first primary objective of this study is to implement a 66-day structured daily diary with 90 HIV-positive YMSM to explore relationships among daily mood, stressful events, social support, substance use, sexual behavior, and adherence to ART among youth who are currently prescribed to take medication.

    Measured: 66 days

  2. Rate of Completion of 66-Day Structured Daily Diary by Modality Type

    The second primary objective is to explore the feasibility and acceptability of using two daily diary modalities (IVR and IWR) as (1) a novel method of data collection in research involving HIV-positive YMSM, and (2) a potential tool to provide personalized feedback and/or assist with self-monitoring among HIV-positive YMSM.

    Measured: 66 days

  3. Reasons and Rate of for Non-completion of 66-Day Structured Daily Diary

    The second primary objective is to explore the feasibility and acceptability of using two daily diary modalities (IVR and IWR) as (1) a novel method of data collection in research involving HIV-positive YMSM, and (2) a potential tool to provide personalized feedback and/or assist with self-monitoring among HIV-positive YMSM.

    Measured: 66 days

Secondary outcomes (1)
  1. Participant Responses to how Diary can Provide Personalized Feedback on Triggers to Risk Behaviors

    The secondary objective of this study is to obtain feedback from HIV-positive YMSM on how the diary could be used to provide personalized feedback on triggers to risk behaviors, such as substance use, unprotected sexual behavior, and poor medication adherence. These data will be obtained through debriefing interviews.

    Measured: 66 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2013 (estimated)
  2. Study startFeb 2013
  3. Primary completionFeb 2014
  4. Study completionFeb 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
67 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01953653
Sponsor's protocol ID
ATN 112
Status last verified
Mar 2016
First submitted
19 Jan 2013
Last updated
28 Feb 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Structured daily diary in people with HIV Infection, run by University of North Carolina, Chapel Hill at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants who Complete the 66-Day Structured Daily Diary (time frame: 66 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in